Following the signing of an executive order by President Donald Trump, which instructs the Food and Drug Administration (FDA) to accelerate the review of psychedelics that show potential to treat conditions such as post-traumatic stress disorder (PTSD), interest in these substances has been reappearing as a way to revolutionize the pharmaceutical industry.
This has fueled the proliferation of retreats around the world. Companies offer multi-day experiences, often promising psychological healing and inner growth. Linked Press (AP) states that many psychedelic retreats have safety procedures, but still carry a “potential for physical, psychological and interpersonal harm,” as researchers surveyed warned, according to an article published in JAMA Network Inaugurates.
Despite the popularity of the withdrawals, the drugs used are illegal under US federal law. The use of these substances is often covered by legal exceptions, although they are rare. The lack of regulation in the industry raises concerns about the quality of care. There are no clear standards for the preparation and monitoring of participants, which can lead to significant risks.
Psychedelic withdrawals are illegal
Virtually all drugs offered at retreats are illegal under US federal law, including hallucinogenic mushrooms, ayahuasca, MDMA, and LSD (lysergic acid diethylamide).
While companies that host retreats don’t always make it clear or sometimes claim to be protected by a rare factual exemption for religious organizations that traditionally use psychedelics, he notes AP.
Only formally has that factual status been obtained by the Native American Church, which uses peyote in its ceremonies.
What is Trump after?
President Donald Trump ordered his administration to expedite reviews of certain psychedelic drugs, including ibogaine, a potent substance that induces users an intense, sometimes emotionally disturbing trip that lasts several hours.
It is promoted as a treatment for traumatic brain injuries and opioid addiction.
Trump declared that the federal government will invest $50 million in research into psychedelic substances. It is also facilitating the administration of ibogaine to critically ill patients, under the FDA’s “Right to Try” regulations.
“Today’s order will ensure that people suffering from debilitating symptoms finally have a chance to get their lives back and be happier,” Trump said. “Everyone is very eager for this. It is for many people, but it is for our veterans in particular,” he stressed.
Safety procedures and medical tests
The screening process to prevent people with serious medical conditions from participating is insufficient. Many retreats rely on attendees’ self-assessment, which may underestimate the risks.
Let us remember that so far the only drug that has reached the FDA, MDMA (3,4-methylenedioxymethamphetamine), known as ecstasy or Molly, was rejected as a treatment for PTSD in 2024, due to concerns about its safety and effectiveness.
A high percentage of withdrawals recommend discontinuation of medications before participating, which could have difficult implications on the mental health of the attendee. Experts warn about the need for professional supervision during this period.
As interest in psychedelic retreats continues to grow, it is clear that it is very important to conduct thorough research and question safety practices. The well-being of the participants depends on rigorous attention to health and the environmental conditions in these retreats.
Testimonials shared by people
People who have participated in psychedelic retreats often share testimonies of profound transformations, such as emotional release, greater mental clarity, and intense spiritual connections.
Emotional benefits
- Many describe healing from deep traumas, such as grief from divorce or childhood abuse, by processing repressed emotions in a safe environment.
- Participants report immediate inner peace after ceremonies with ayahuasca or psilocybin, overcoming years of traditional therapy without such results.
Changes in perspective
- Executives and professionals notice a psychological “reset”, becoming less controlling, more empathetic and focused, with a reduction in somatized anxiety.
- Others experience a spiritual awakening, reconnecting with ancestors, nature, or a sense of cosmic unity that restores faith and awe in life.
Long term effects
- After retreats, increased creativity, strengthened community, and improved bodily sensitivity emerge, similar to prolonged spiritual practices.
- Juan Ramírez, for example, emerged from an emotional dead end, reconciling with himself and avoiding suicidal thoughts.
You may also be interested in:
· Nicotine pouches are promoted by influencers without mentioning health risks
· They warn that popular energy drink influenced the fatal cardiac outcome of a cheerleader
· Carfentanil spreads in the US, a drug 100 times more powerful than fentanyl
